•  
  •  
  •  
  •  

2025-11-27 07:17:51

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Lenskart Partners with Labubu Maker Popmart's Sweet Bean to Launch a Limited-Edition Collection on 4 Dec in Singapore
  • Salasar Techno Engineering Ltd bags two contracts worth Rs. 695.18 crores
  • Indo-Tech Transformers Ltd receives order worth Rs. 91.26 crores
  • Kesar India Ltd acquires Plot at Nagpur, Maharashtra having Revenue potential of Rs. 900 Crore
  • BOBCARD LIMITED Launches Cashback Credit Card, Promising 'Happy Returns' on Every Spend

Keywords Selected:  GMPInspection

Stock Report

  • GMP Inspection by Ministry of Health, Armenia at Alkem's manufacturing facility located at Sikkim, India
  • Biocon Limited updates on GMP inspection by USFDA at its Cranbury, New Jersey facility
  • Tyche Industries Ltd completes GMP inspection by ANVISA
  • Concord Biotech Ltd successfully completes Russian GMP insepction at its API facility
  • EIR from USFDA, for Shilpa Medicare Ltd. Unit VI, Bengaluru.
  • Shilpa Pharma Lifesciences Limited, Unit-1, ANVISA Audit from Brazil
  • Sun Pharma gets 8 observations from USFDA for Halol facility
  • Piramal Pharma Ltd completes USFDA inspection of Aurora facility with Zero Form-483 observations
  • USFDA completes GMP inspection at Dr. Reddy's Laboratories Ltd's API Middleburgh facility
  • ANSM Inspection at Cenexi's Fontenay Manufacturing Facility
  • Torrent Pharmaceuticals Ltd receives Form 483 from USFDA for Formulation Facility
  • Shilpa Pharma Lifesciences Ltd's Unit 2, Raichur, Karnataka has cleared the COFEPRIS-Mexico GMP Inspection
  • USFDA completes cGMP inspection of Divi's Laboratories Limited's Unit 2
  • Cipla Limited's Kurkumbh facility gets VAI classification from USFDA
  • Shilpa Pharma Lifesciences Ltd, Unit 2, Raichur, Karnataka has cleared the ANVISA-Brazil GMP inspection
  • Torrent Pharmaceuticals Ltd gets Form 483 with 5 observations for Indrad facility
  • Dr. Reddy's Laboratories Limited gets Form 483 from USFDA with 4 observations for API facility
  • Ami Organics'Limited, Unit I, Sachin, Surat in Gujarat has cleared PMDA Japan, GMP Inspection
  • Everest Organics Ltd updates on USFDA inspection
  • U.S. FDA completes inspection of Lupin's Dabhasa Facility with No Observations
  • EDQM conducts GMP inspection of SMS Pharmaceuticals Ltd's API facility
  • Shilpa Medicare Ltd updates on Europe GMP inspection at Unit 4, Jadcherla, Telangana
  • Granules Pharmaceuticals Inc gets 5 observations from USFDA on completion of GMP inspection
  • Biocon Ltd - Update on U.S. FDA Inspection at Biocon Biologics' Manufacturing Facility in Johor, Malaysia

Latest Post

  • Lenskart Partners with Labubu Maker Popmart's Sweet Bean to Launch a Limited-Edition Collection on 4 Dec in Singapore
  • Salasar Techno Engineering Ltd bags two contracts worth Rs. 695.18 crores
  • Indo-Tech Transformers Ltd receives order worth Rs. 91.26 crores
  • Kesar India Ltd acquires Plot at Nagpur, Maharashtra having Revenue potential of Rs. 900 Crore
  • BOBCARD LIMITED Launches Cashback Credit Card, Promising 'Happy Returns' on Every Spend


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024